The results of the SURE-PD trial revealed that treatment with inosine for up to 24 months was clinically safe and well-tolerated at doses that elevated serum UA concentrations from a mean of 4.5 mg/dL to 6.17.0 and 7.18.0 mg/dL [104]
Proposed mechanisms include oxidative stress, mitochondrial dysfunction, dyslipidaemia, and genomic modulation of hypertrophic and fibrotic signalling pathways (70)
Investigation includes liver function tests, renal function, full blood count, and imaging if malignancy or liver disease suspected
Ketone body 3-hydroxybutyrate mimics calorie restriction via the Nrf2 activator, fumarate, in the retina
2016;146(2):433S-436S
Cyrus Sedaghat in Orange County, this therapy ensures your internal defense network is always fully charged and ready to combat seasonal threats and environmental pollutants